Strides Arcolab is currently trading at Rs. 878.50, up by 14.30 points or 1.65 % from its previous closing of Rs. 864.20 on the BSE.
The scrip opened at Rs. 884.00 and has touched a high and low of Rs. 895.00 and Rs. 794.30 respectively. So far 840839 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 1200.00 on 21-Dec-2012 and a 52 week low of Rs. 552.65 on 01-Aug-2013.
Last one week high and low of the scrip stood at Rs. 1050.00 and Rs. 835.00 respectively. The current market cap of the company is Rs. 5199.35 crore.
The promoters holding in the company stood at 27.36% while Institutions and Non-Institutions held 58.54% and 14.11% respectively.
Strides Arcolab has declared a special dividend of Rs 500 per share in the wake of the $1.75-billion sale of its Agila Specialities Division to Mylan Inc of the US. The company returned 88% of the free cash available with it to the shareholders by way of special dividend.
Initially, the company had planned to distribute $700 million-$800 million pre-tax to the shareholders. But the board approved the special dividend of Rs 500 for a share, which would result in a pre-tax distribution of about $525 million.
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1904.65 |
| Dr. Reddys Labs. | 1374.55 |
| Cipla | 1458.45 |
| Zydus Lifesciences | 1141.00 |
| Lupin | 2476.10 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: